Target intelligence / Profile preview

Salsola kali pollen allergens (Sal k allergens)

Target
Sal k allergens
Molecular classification
Allergen, Protein, Enzyme
01

Overview

Salsola kali, commonly known as Russian thistle or tumbleweed, is a major source of highly allergenic pollen in arid and semi-arid regions worldwide. The immune response to these allergens is a classic Type I hypersensitivity reaction mediated by allergen-specific IgE antibodies. The primary molecular targets within this response are the specific proteins found in the pollen, most notably Sal k 1 (a pectin methylesterase), which is recognized by the majority of sensitized individuals (Barderas et al., 2004, PMID: 15125714). Other significant allergens include Sal k 2 (a kinase-related protein) and Sal k 3 (cobalamin-independent methionine synthase) (WHO/IUIS Allergen Nomenclature). Upon inhalation, these allergens cross-link IgE on mast cells and basophils, triggering the release of inflammatory mediators that cause allergic rhinitis, conjunctivitis, and bronchial asthma. While symptomatic treatments like antihistamines and corticosteroids manage the downstream effects of the immune response, allergen-specific immunotherapy (AIT) using Salsola kali extracts remains the only disease-modifying approach aimed at inducing long-term immune tolerance (Assarehzadegan et al., 2009, PMID: 19364562).

Other names
Russian thistle pollen allergensSalsola tragus allergensSal k 1Sal k 2Sal k 3Sal k 4Sal k 5Pectin methylesterase Sal k 1
02

Mechanism of action

Allergen-specific immunotherapy (AIT) involves the administration of standardized Salsola kali extracts to induce immunological tolerance. This is achieved by shifting the T-cell response from a Th2-dominated allergic profile to a Th1 and regulatory T-cell (Treg) profile, alongside the production of IgG4 blocking antibodies that prevent IgE-mediated mast cell degranulation (Gadermaier et al., 2014, PMID: 24601633).

03

Biological functions

Immune responseIgE bindingType I hypersensitivityHistamine release
04

Disease associations

Allergic rhinitisAsthmaConjunctivitisPollinosis
05

Safety considerations

Risk of systemic anaphylaxis during immunotherapyLocal injection site reactionsCross-reactivity with other Chenopodiaceae and Amaranthaceae species
06

Interacting drugs

Salsola kali pollen extract

4 more in the full profile.

07

Biomarkers

Specific IgE (sIgE) to Sal k 1Skin prick test (SPT) reactivityBasophil activation test (BAT)Specific IgG4 levels

Beyond the preview

Go deeper on Salsola kali pollen allergens (Sal k allergens).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salsola kali pollen allergens (Sal k allergens).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call